Checkmate Capital appeared to be the VC, which was created in 2017. The company was established in North America in United States. The main department of described VC is located in the Los Angeles.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Oil and Gas, Life Science. Among the most popular portfolio startups of the fund, we may highlight bcause, TELA Bio. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The overall number of key employees were 4.
The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Checkmate Capital, startups are often financed by Signet Healthcare Partners, SBI Group, Quaker Partners.
Related Funds
Funds with similar focus
Fund Name | Location |
Allaire Corporation | Massachusetts, Newton, United States |
Canadian Medical Association | Canada, Ontario, Ottawa |
Chongqing Xingliji Touzi Co., Ltd | China, Chongqing, Chongqing Shi |
Endeavor | New York, New York, United States |
Harrington Global | - |
KBC Focus Fund | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
Linqin Chuangtou | China, Dongguang, Guangdong |
Poalim Electronic Communication | - |
Transatlantic Venture Mangment Inc. | Cambridge, Massachusetts, United States |
Twin Capital | Lees Summit, Missouri, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Bredis | 19 May 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Lynx Biosciences, Inc. | 03 Nov 2021 | San Diego, California, United States | |||
Elucid | $10M | 10 May 2021 | Boston, Massachusetts, United States | ||
Lactiga | $1M | 01 Dec 2020 | Old Toronto, Ontario, Canada | ||
$1M | 08 Apr 2020 | Los Angeles, California, United States | |||
SiteFuel | $5M | 25 Apr 2018 | California, United States | ||
TELA Bio | 16 Apr 2018 | Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Bredis | 19 May 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Lynx Biosciences, Inc. | 03 Nov 2021 | San Diego, California, United States | |||
Elucid | $10M | 10 May 2021 | Boston, Massachusetts, United States | ||
Lactiga | $1M | 01 Dec 2020 | Old Toronto, Ontario, Canada | ||
$1M | 08 Apr 2020 | Los Angeles, California, United States | |||
SiteFuel | $5M | 25 Apr 2018 | California, United States | ||
TELA Bio | 16 Apr 2018 | Pennsylvania, United States |